Literature DB >> 32319732

Clinical findings of 21 previously unreported probands with HNRNPU-related syndrome and comprehensive literature review.

Anna Durkin1, Shadi Albaba2, Andrew E Fry3, Jenny E Morton4, Andrew Douglas5,6, Ana Beleza7, Denise Williams4, Catharina M L Volker-Touw8, Sally A Lynch9, Natalie Canham10, Virginia Clowes11, Volker Straub12, Katherine Lachlan6, Frances Gibbon13, Mayy El Gamal13, Vinod Varghese3, Michael J Parker14, Ruth Newbury-Ecob15, Peter D Turnpenny16, Alice Gardham17, Neeti Ghali17, Meena Balasubramanian14,18.   

Abstract

With advances in genetic testing and improved access to such advances, whole exome sequencing is becoming a first-line investigation in clinical work-up of children with developmental delay/intellectual disability (ID). As a result, the need to understand the importance of genetic variants and its effect on the clinical phenotype is increasing. Here, we report on the largest cohort of patients with HNRNPU variants. These 21 patients follow on from the previous study published by Yates et al. in 2017 from our group predominantly identified from the Deciphering Developmental Disorders study that reported seven patients with HNRNPU variants. All the probands reported here have a de novo loss-of-function variant. These probands have craniofacial dysmorphic features, in the majority including widely spaced teeth, microcephaly, high arched eyebrows, and palpebral fissure abnormalities. Many of the patients in the group also have moderate to severe ID and seizures that tend to start in early childhood. This series has allowed us to define a novel neurodevelopmental syndrome, with a likely mechanism of haploinsufficiency, and expand substantially on already published literature on HNRNPU-related neurodevelopmental syndrome.
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990HNRNPU; DDD study; exome sequencing; intellectual disability; seizures

Year:  2020        PMID: 32319732     DOI: 10.1002/ajmg.a.61599

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants.

Authors:  Kohei Hamanaka; Noriko Miyake; Takeshi Mizuguchi; Satoko Miyatake; Yuri Uchiyama; Naomi Tsuchida; Futoshi Sekiguchi; Satomi Mitsuhashi; Yoshinori Tsurusaki; Mitsuko Nakashima; Hirotomo Saitsu; Kohei Yamada; Masamune Sakamoto; Hiromi Fukuda; Sachiko Ohori; Ken Saida; Toshiyuki Itai; Yoshiteru Azuma; Eriko Koshimizu; Atsushi Fujita; Biray Erturk; Yoko Hiraki; Gaik-Siew Ch'ng; Mitsuhiro Kato; Nobuhiko Okamoto; Atsushi Takata; Naomichi Matsumoto
Journal:  Genome Med       Date:  2022-04-26       Impact factor: 15.266

2.  SAF-A mutants disrupt chromatin structure through dominant negative effects on RNAs associated with chromatin.

Authors:  Heather J Kolpa; Kevin M Creamer; Lisa L Hall; Jeanne B Lawrence
Journal:  Mamm Genome       Date:  2021-12-02       Impact factor: 3.224

Review 3.  Expanding the phenotype of HNRNPU-related neurodevelopmental disorder with emphasis on seizure phenotype and review of literature.

Authors:  James Taylor; Michael Spiller; Kara Ranguin; Antonio Vitobello; Christophe Philippe; Ange-Line Bruel; Gerarda Cappuccio; Nicola Brunetti-Pierri; Marjolaine Willems; Bertrand Isidor; Kristen Park; Meena Balasubramanian
Journal:  Am J Med Genet A       Date:  2022-02-09       Impact factor: 2.578

Review 4.  Influence of Age on Skeletal Muscle Hypertrophy and Atrophy Signaling: Established Paradigms and Unexpected Links.

Authors:  Eun-Joo Lee; Ronald L Neppl
Journal:  Genes (Basel)       Date:  2021-05-03       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.